Exelixis Inc
XNAS:EXEL 4:00:00 PM EDT
| Market Cap (Intraday) | 12.50B |
| Current PE | 18.43 |
| Forward PE | 16.07 |
| 2yr Forward PE | 14.48 |
| 10-Day MA | $43.78 |
| 50-Day MA | $41.23 |
| 200-Day MA | $40.12 |
Exelixis Inc Stock, XNAS:EXEL
1851 Harbor Bay Parkway, Alameda, California 94502
United States of America
Phone: +1.650.837.7000
Number of Employees: 1147
Description
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.